Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1

Preformed Fas ligand (FasL) and APO2 ligand (APO2L)/TNF-related apoptosis-inducing ligand (TRAIL) are stored in the cytoplasm of the human Jurkat T cell line and of normal human T cell blasts. The rapid release of these molecules in their bioactive form is involved in activation-induced cell death. In this study, we show by confocal microscopy that FasL and APO2L/TRAIL are mainly localized in lysosomal-like compartments in these cells. We show also by immunoelectron microscopy that FasL and APO2L/TRAIL are stored inside cytoplasmic compartments ∼500 nm in diameter, with characteristics of multivesicular bodies. Most of these compartments share FasL and APO2L/TRAIL, although exclusive APO2L/TRAIL labeling can be also observed in separate compartments. Upon PHA activation, the mobilization of these compartments toward the plasma membrane is evident, resulting in the secretion of the internal microvesicles loaded with FasL and APO2L/TRAIL. In the case of activation with anti-CD59 mAb, the secretion of microvesicles labeled preferentially with APO2L/TRAIL predominates. These data provide the basis of a new and efficient mechanism for the rapid induction of autocrine or paracrine cell death during immune regulation and could modify the interpretation of the role of FasL and APO2L/TRAIL as effector mechanisms in physiological and pathological situations.

[1]  P. Ricciardi-Castagnoli,et al.  Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.

[2]  E. Nabel,et al.  Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity , 2001, Nature Immunology.

[3]  P. Möller,et al.  CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies , 2001, Cell Death and Differentiation.

[4]  R. Siegel,et al.  The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity , 2000, Nature Immunology.

[5]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[6]  L. Page,et al.  Sorting out the multiple roles of Fas ligand. , 2000, European journal of cell biology.

[7]  J K Frederiksen,et al.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. , 2000, Science.

[8]  P. Golstein FasL Binds Preassembled Fas , 2000, Science.

[9]  B. Hoflack,et al.  Bi-directional trafficking between the trans-Golgi network and the endosomal/lysosomal system. , 2000, Journal of cell science.

[10]  S. Ju,et al.  Bioactivities of Fas Ligand-Expressing Retroviral Particles1 , 2000, The Journal of Immunology.

[11]  L. Mincheva-Nilsson,et al.  gammadelta T cells of human early pregnancy decidua: evidence for cytotoxic potency. , 2000, International immunology.

[12]  M. Martínez-Lorenzo,et al.  CD59 cross‐linking induces secretion of APO2 ligand in overactivated human T cells , 2000, European journal of immunology.

[13]  P. Krammer,et al.  Tumor counterattack – concept and reality , 2000, European journal of immunology.

[14]  Laurence Zitvogel,et al.  Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.

[15]  M. Martínez-Lorenzo,et al.  Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.

[16]  K. Iwabuchi,et al.  Chemotactic activity of soluble Fas ligand against phagocytes. , 1998, Journal of immunology.

[17]  M. Martínez-Lorenzo,et al.  Involvement of APO2 ligand/TRAIL in activation‐induced death of Jurkat and human peripheral blood T cells , 1998, European journal of immunology.

[18]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[19]  H. Geuze,et al.  Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.

[20]  J. Tschopp,et al.  Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.

[21]  S. Nagata,et al.  Downregulation of Fas ligand by shedding , 1998, Nature Medicine.

[22]  T. Ochi,et al.  Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing , 1997, The Journal of experimental medicine.

[23]  M. Hanani,et al.  Immunoreactivity for the Fas ligand in the mammalian enteric nervous system , 1997, Cell and Tissue Research.

[24]  K. Okumura,et al.  Antitumor effect of locally produced CD95 ligand , 1997, Nature Medicine.

[25]  M. Martínez-Lorenzo,et al.  Release of preformed Fas ligand in soluble form is the major factor for activation‐induced death of Jurkat T cells , 1996, Immunology.

[26]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[27]  S. Yonehara,et al.  Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. , 1996, Journal of immunology.

[28]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[29]  A. Kawasaki,et al.  Metalloproteinase-mediated release of human Fas ligand , 1995, The Journal of experimental medicine.

[30]  M. Lenardo,et al.  Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.

[31]  Masato Tanaka,et al.  Expression of the functional soluble form of human fas ligand in activated lymphocytes. , 1995, The EMBO journal.

[32]  P. Krammer,et al.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.

[33]  S. Ju,et al.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation , 1995, Nature.

[34]  Seamus J. Martin,et al.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.

[35]  C. Smith,et al.  Fas ligand mediates activation-induced cell death in human T lymphocytes , 1995, The Journal of experimental medicine.

[36]  P. Golstein,et al.  T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A , 1994, European journal of immunology.

[37]  J. Inazawa,et al.  Human Fas ligand: gene structure, chromosomal location and species specificity. , 1994, International immunology.

[38]  A. Abbas,et al.  The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. , 1994, Immunity.

[39]  P. Golstein,et al.  Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway? , 1994, European journal of immunology.

[40]  Peter J. Peters Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes , 1991, The Journal of experimental medicine.

[41]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[42]  G. Griffiths,et al.  Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells , 1999, Nature Medicine.

[43]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[44]  M. Shannon,et al.  Lead and caries , 1998, Nature Medicine.

[45]  P. Ehrlich Granules of the Human Neutrophilic Polymorphonuclear Leukocyte , 1997 .

[46]  J. Russell,et al.  Activation-induced death of mature T cells in the regulation of immune responses. , 1995, Current opinion in immunology.

[47]  E. Kellenberger,et al.  Low-Temperature Embedding , 1986 .